U.S.’ Biotech Scrutiny Tests China’s Drugmakers Abroad. U.S. lawmakers’ push to scrutinize biotechnology ties with China is ...

Sales and land investments are increasingly concentrated in Beijing, Shanghai, Guangzhou, and Shenzhen as the broader real ...

New thresholds on price and motor power effectively block lower-cost fully built imports from BYD, Zeekr and Chery as Kuala ...

The former head of Hunan province’s emergency-management department is among the latest to be investigated as authorities ...

Unitree gets China’s approval to list on Shanghai’s STAR Market, advancing a planned fundraising of about $618 million as ...

The upcoming rollout of the latest global Common Reporting Standard will tighten scrutiny of offshore accounts, trusts and ...

PwC’s forecast tops rival Big Four estimates, even as rate risks, mainland capital rules and a falling Hang Seng Index cloud ...

Backed by Changan, CATL and Huawei, the premium EV maker is seeking a listing after losses widened and sales fell sharply in ...

China Chengxin abruptly removes the newly published guidelines from its website following speculation the mechanism was ...

The contribution of high value-added industries such as biomedicine to China’s total economic inputs jumped in June, driven ...

A short-term tariff truce between Washington and New Delhi appears imminent, but domestic infrastructure deficits and ...

The tech boom underscores a stark market divide as traditional mainstays like real estate and banking slump by double digits ...